Medical research

Team delivers breakthrough 'nanobody' technology

Researchers led by Professor Steve Watson and Dr. Eleyna Martin from the Institute of Cardiovascular Sciences at the University of Birmingham have delivered a breakthrough for thrombosis researchers, by producing the first ...

Diseases, Conditions, Syndromes

Study helps explain SARS-CoV-2 variants' rapid spread

The omicron variants of the SARS-CoV-2 virus, which have rapidly spread around the world over the past year, latch onto our cells more tightly, invade them more efficiently, and elude many of the antibodies induced by previous ...

Diseases, Conditions, Syndromes

Chemists' technique reveals whether antibodies neutralize SARS-CoV-2

Antibodies that can disarm a virus, known as neutralizing antibodies, are key to the body's ability to fight off infection. MIT chemists have come up with a new way to identify these neutralizing antibodies in a blood sample, ...

Medications

How long-term benzodiazepine use leads to cognitive impairments

Benzodiazepines are effective and widely used drugs for treating states of anxiety and sleep disorders. While short-term treatments are considered safe, their long-term intake can lead to physical dependence and, particularly ...

Oncology & Cancer

A leap forward in research on CAR T cell therapy

In cancer immunotherapy, cells in the patient's own immune system are activated to attack cancer cells. CAR T cell therapy has been one of the most significant recent advances in immunotherapies targeted at cancer.

page 2 from 5